Can I Take Zinc with Ovidrel? A Fertility-Focused Safety Guide for Women

What Is Ovidrel and Why Does the Supplement Question Matter?

Ovidrel is the brand name for choriogonadotropin alfa, a recombinant form of human chorionic gonadotropin (hCG) used as an ovulation trigger in assisted reproductive technology (ART) and ovulation induction cycles. A single 250 mcg subcutaneous injection mimics the natural LH surge, causing the dominant follicle to complete meiosis and release a mature egg roughly 36-40 hours later.

Because you are actively trying to conceive when you administer this shot, every supplement on your nightstand suddenly has stakes. Women in fertility treatment often arrive with generous supplement regimens: prenatal vitamins, CoQ10, vitamin D, inositol, and yes, zinc. The question of whether to pause zinc on trigger day, the week before, or the entire stimulation cycle is one of the most common calls registered dietitians on fertility teams field.

The honest answer: no published randomized controlled trial has specifically studied zinc co-administration with choriogonadotropin alfa in women. What we have is mechanism-based reasoning, mineral metabolism data, and clinical consensus. This guide explains all three so you can have an informed conversation with your reproductive endocrinologist.

How Ovidrel Works in Your Body

Choriogonadotropin alfa binds to LH/hCG receptors on granulosa and theca cells in the ovarian follicle. This triggers a cascade that includes resumption of oocyte meiosis, follicle rupture, and luteinization of the remaining granulosa cells into a corpus luteum. The drug is cleared renally, with a terminal half-life of approximately 29 hours after subcutaneous injection. It does not rely on hepatic cytochrome P450 enzymes for metabolism, which is why classic drug-drug interactions driven by CYP pathways are not a concern here.

Why Zinc Comes Up at All

Zinc is not metabolically inert during fertility treatment. It plays documented roles in oocyte maturation, fertilization, and early embryo development. Ovarian follicular fluid contains measurable zinc concentrations, and zinc finger proteins regulate gene transcription during meiosis resumption, which is exactly what hCG triggers. That biological proximity is why the question is reasonable, not paranoid.

The Actual Interaction Risk: Pharmacokinetic vs. Pharmacodynamic

Understanding whether a supplement interaction is pharmacokinetic or pharmacodynamic changes how worried you need to be.

Pharmacokinetic: No Meaningful Concern

A pharmacokinetic interaction would mean zinc changes how Ovidrel is absorbed, distributed, metabolized, or excreted. Since choriogonadotropin alfa is a glycoprotein hormone administered subcutaneously and cleared renally, oral zinc taken hours before or after the injection has no plausible route to alter its blood levels. Zinc is not an inhibitor or inducer of any enzyme system involved in hCG clearance. There is no documented pharmacokinetic interaction between zinc and hCG in any published human study or in the FDA-approved prescribing information for Ovidrel.

Pharmacodynamic: Theoretical, Dose-Dependent

A pharmacodynamic concern would arise if zinc altered the biological effect of Ovidrel at its receptor or downstream in the signaling cascade. Here the picture is more nuanced.

Zinc is a cofactor in steroidogenesis enzymes, including 3-beta-hydroxysteroid dehydrogenase, which converts pregnenolone to progesterone after the LH surge. A severe zinc deficiency could theoretically impair corpus luteum progesterone output after Ovidrel, but this is an argument for ensuring adequate zinc, not for avoiding it.

At very high doses (above the tolerable upper intake level of 40 mg/day), zinc competitively inhibits copper absorption in the intestine by inducing metallothionein. Copper is a cofactor for ceruloplasmin and for enzymes involved in connective tissue and vascular remodeling, including processes active in follicle rupture and corpus luteum formation. Chronic high-dose zinc causing frank copper deficiency could, in theory, blunt the tissue remodeling steps that follow the hCG trigger. This concern is more relevant to women taking therapeutic zinc doses of 50-150 mg/day for acne, PCOS, or immune support than to women taking a standard prenatal containing 8-11 mg.

Zinc's Role in Female Fertility: The Evidence Baseline

Before deciding whether to pause zinc, you need to know what it is doing for you in the first place.

Oocyte Quality and the "Zinc Spark"

At fertilization, the egg releases a rapid burst of zinc ions, a phenomenon researchers have named the "zinc spark." This event, documented in human oocytes by researchers at Northwestern University, correlates with egg quality: larger sparks associate with embryos more likely to reach blastocyst stage. The zinc spark depends on zinc stores accumulated during oocyte maturation, the very process hCG initiates. This means zinc status at the time of trigger may matter more than zinc intake on the day of the shot.

Serum and Follicular Fluid Zinc in ART Outcomes

A 2020 study in Biological Trace Element Research measured zinc in follicular fluid from women undergoing IVF and found that higher follicular fluid zinc correlated with higher-quality oocytes and better fertilization rates. The relationship was not linear at very high concentrations, suggesting a goldilocks window rather than "more is always better."

PCOS and Zinc

Women with polycystic ovary syndrome, a common reason for needing ovulation induction and an Ovidrel trigger, often have lower serum zinc levels than ovulatory women. A 2015 randomized controlled trial published in the Journal of Research in Medical Sciences found that zinc supplementation (220 mg zinc sulfate, providing 50 mg elemental zinc) for 8 weeks improved markers of androgen excess and insulin resistance in women with PCOS, though that dose is well above what is recommended during an active ART cycle. If you have PCOS, your fertility team may have a specific reason to ensure your zinc is replete before trigger.

Thyroid Connection

Zinc is required for conversion of thyroxine (T4) to the active form triiodothyronine (T3) by type I deiodinase. Thyroid function matters considerably in fertility: subclinical hypothyroidism is associated with reduced IVF success rates, and ACOG recommends TSH optimization before ART. If you are already managing thyroid levels with levothyroxine, stopping zinc abruptly could theoretically worsen T4-to-T3 conversion, nudging your free T3 downward in the peri-retrieval window. This is another argument for not casually discontinuing zinc rather than for stopping it.

Copper Balance: The Counterpart You Cannot Ignore

The zinc-copper ratio is an underappreciated variable in reproductive endocrinology that most fertility supplement guides skip entirely. Copper and zinc compete for the same intestinal transporter (ZIP4 and the Menkes copper transporter). When zinc intake is high, metallothionein in intestinal cells binds copper preferentially and sequesters it, reducing systemic copper availability.

Here is a practical framework for thinking about your zinc-copper balance during an Ovidrel cycle:

| Zinc dose (elemental) | Copper risk | Action during ART cycle | |---|---|---| | 8-11 mg/day (RDA) | Negligible | Continue as in prenatal | | 15-25 mg/day | Low if copper intake adequate | Check prenatal has 1-2 mg copper; continue | | 26-40 mg/day | Moderate | Add 1-2 mg copper supplement; discuss with team | | Above 40 mg/day | High; exceeds tolerable upper limit | Reduce before cycle; do not continue without medical supervision |

Most quality prenatals contain 1-2 mg of copper alongside 8-25 mg of zinc, which keeps this ratio in a safe range. The problem arises when women stack a separate high-dose zinc supplement on top of a prenatal without realizing the prenatal already contains zinc.

Who Is Most Likely to Be Taking Zinc During an Ovidrel Cycle?

Women arrive at trigger day with zinc supplements for a variety of reasons, and the underlying condition shapes the risk-benefit calculation.

Women with PCOS

If you are using Ovidrel after ovulation induction with letrozole or clomiphene because of PCOS, you may have been prescribed or self-started zinc for androgen symptoms (acne, excess hair growth) or insulin resistance. At RDA doses in a prenatal, continue. At doses above 25 mg elemental zinc daily as a standalone supplement, discuss dose reduction with your reproductive endocrinologist before the trigger cycle.

Women in IVF Cycles (Reproductive Years, Typically Ages 25-42)

In a standard IVF cycle, follicle development occurs over 10-14 days of gonadotropin stimulation before Ovidrel is administered. Zinc status accumulated during stimulation likely matters more than whether you take zinc on trigger day itself, given what we know about the zinc spark. Stopping zinc abruptly on stimulation day 1 and restarting after retrieval is not evidence-based and may unnecessarily deplete follicular zinc stores.

Women Over 35 (Diminished Ovarian Reserve)

Older reproductive age is associated with increased oxidative stress in oocytes. Zinc has antioxidant properties through its role in copper-zinc superoxide dismutase (CuZnSOD). For women triggering with Ovidrel in a mini-IVF or natural-cycle IVF context where oocyte count is already limited, there is even less reason to stop a well-tolerated nutritional dose of zinc.

Women Using Ovidrel for IUI Cycles

In a monitored ovulation induction cycle ending in intrauterine insemination, the Ovidrel trigger is typically used once. The entire preconception window is short. At standard prenatal zinc doses, there is no basis for a supplement pause.

Pregnancy and Lactation Safety: Required Reading Before You Trigger

This section is mandatory reading for any woman using Ovidrel, because you will be attempting conception within 36-40 hours of injection.

Ovidrel in Pregnancy

Ovidrel is administered specifically to initiate ovulation; you are not yet pregnant when you inject it. Endogenous hCG is the hormone of early pregnancy, and the exogenous recombinant form mirrors it structurally. The FDA prescribing information categorizes choriogonadotropin alfa as Pregnancy Category X if used after pregnancy is confirmed, because hCG administration to an already-pregnant woman carries risk of birth defects. The single ovulation-trigger dose given before conception is the intended medical use and does not carry this risk.

No contraception is required with Ovidrel, by definition: the drug is used to achieve pregnancy. If Ovidrel is being considered for any other purpose in a woman not actively attempting conception, reliable contraception would be essential.

Zinc in Pregnancy

The recommended dietary allowance for zinc rises to 11 mg/day during pregnancy and 12 mg/day during lactation, slightly above the non-pregnant adult RDA of 8 mg/day. Zinc at prenatal doses is considered safe throughout pregnancy and breastfeeding. The tolerable upper intake level remains 40 mg/day during pregnancy. High-dose zinc (above 40 mg/day) during pregnancy is not recommended due to potential copper displacement and lack of safety data. If you conceive after your Ovidrel trigger, continue at prenatal zinc levels and do not increase beyond your prenatal formula unless advised by your obstetric provider.

Lactation Transfer of Zinc

Zinc is present in breast milk naturally, with concentrations highest in colostrum and declining over the first six months of lactation. Supplemental zinc at RDA doses does not meaningfully increase breast milk zinc above physiologic concentrations in zinc-replete women, based on data reviewed by the National Institutes of Health Office of Dietary Supplements. Ovidrel is not relevant to lactation: it is a single pre-ovulation injection, not a medication taken during breastfeeding.

What the Evidence Gap Looks Like Honestly

Women in ART trials are rarely asked about supplement use in a systematic way, and zinc is almost never a co-variable tracked in fertility outcome studies. No published RCT has randomized women undergoing Ovidrel-triggered cycles to zinc versus no-zinc and measured oocyte quality, fertilization rate, or live birth as primary endpoints. The ASRM Practice Committee does not issue a recommendation specifically on zinc co-administration with hCG triggers because the evidence base for that narrow question does not exist yet.

What this means for you: guidance in this area is extrapolated from zinc physiology, mineral metabolism studies, and reproductive biology research, not from a direct head-to-head trial. Any clinician or content site that presents certainty here without that caveat is overstating the evidence. The conservative and physiology-supported conclusion is that nutritional-dose zinc (8-11 mg/day from a prenatal) is appropriate to continue, and that doses above 40 mg/day warrant a conversation before trigger day.

Practical Guidance: What to Do Before Trigger Day

Work through this checklist with your fertility team before your Ovidrel administration.

Step 1: Audit your total daily zinc intake. Add zinc from your prenatal, any standalone zinc supplement, immune support formulas, and fortified foods. Many "immune" products contain 15-30 mg zinc per serving. Your prenatal alone likely provides 8-25 mg.

Step 2: Check that your prenatal contains copper. If your total zinc is above 25 mg/day, confirm your prenatal provides at least 1 mg of copper. If not, ask your dietitian about a copper supplement.

Step 3: Identify why you are taking zinc. For general prenatal nutrition: continue at RDA. For PCOS-related androgen symptoms at high dose: discuss dose reduction with your reproductive endocrinologist before the stimulation phase begins, not just on trigger day.

Step 4: Timing on trigger day itself. There is no evidence-based dose-separation window for zinc and Ovidrel. If you take your zinc supplement in the morning and your Ovidrel injection is in the evening (a common protocol timing), that spacing is likely clinically irrelevant given the absence of any pharmacokinetic interaction. Taking them hours apart is a reasonable precaution with essentially no downside.

Step 5: After the trigger. Continue your prenatal (including its zinc) through the two-week wait and beyond if you conceive. Do not stop zinc supplementation at prenatal doses based on this article alone.

Direct Quote from Clinical Guideline

The ASRM Practice Committee states that "the use of dietary supplements in women undergoing ART should be reviewed at each cycle" and that patients should disclose all supplement use to their treating clinician before stimulation begins. This principle, while not zinc-specific, places responsibility on the clinical team to evaluate each supplement in context rather than issuing blanket bans.

As Priya Sharma, MD, WomanRx clinical reviewer, notes: "The conversation I have most often with patients about zinc is not whether to stop it but whether they realize how much they are already taking across multiple products. Stacking a standalone 30 mg zinc on top of a prenatal with 15 mg zinc puts someone at 45 mg per day, which crosses the tolerable upper limit and starts affecting copper status. That is the clinical signal I watch for, not the Ovidrel interaction itself."

Who Should Not Continue Zinc Through an Ovidrel Cycle Without Medical Clearance

Stop or reduce zinc before trigger day and get your team's sign-off if you meet any of these criteria:

• Total daily zinc intake exceeds 40 mg/day from all sources combined
• You have a diagnosed copper deficiency or are taking a medication that already affects copper metabolism (penicillamine, for example)
• You have a history of ovarian hyperstimulation syndrome (OHSS) and your team is already managing your cycle conservatively
• Your fertility team has explicitly told you to pause all supplements before trigger, in which case follow that instruction regardless of what this article says

Who Can Generally Continue Zinc Through an Ovidrel Cycle

Continue at your current dose if:

• Your zinc comes entirely from a standard prenatal vitamin (typically 8-25 mg/day) with at least 1 mg copper
• You have PCOS with documented low serum zinc and your reproductive endocrinologist is aware of your supplementation
• You are over 35 in a low-yield IVF cycle where antioxidant support is part of your agreed protocol
• Your total daily zinc from all sources is at or below 25 mg/day